"Het Anna Ziekenhuis (Geldrop/Eindhoven) is een regionaal ziekenhuis met vrijwel alle disciplines, ruim 90 specialisten en een capaciteit van 320 bedden. Wij bieden persoonlijke, kwalitatief hoogwaardige zorg en service, waarbij de patiënt altijd één op één contact heeft met de specialist. Door onze bijzonder betrokken werkwijze geven wij een extra beleving aan de behandeling van onze patiënten."

During the past decade, St. Anna Ziekenhuis conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 1 clinical trials were completed, i.e. on average, 11.1% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "St. Anna Ziekenhuis" #1 sponsor was "Radboud University Medical Center" with 3 trials, followed by "Stichting Hemato-Oncologie voor Volwassenen Nederland" with 2 trials sponsored, "Zimmer Biomet" with 2 trials sponsored, "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)" with 1 trials sponsored and "Amsterdam UMC, location VUmc" with 1 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "St. Anna Ziekenhuis" #1 collaborator was "ZonMw: The Netherlands Organisation for Health Research and Development" with 2 trials as a collaborator, "Amgen" with 1 trials as a collaborator, "Australasian Leukaemia and Lymphoma Group" with 1 trials as a collaborator, "Central European Myeloma Study Group" with 1 trials as a collaborator and "Comprehensive Cancer Centre The Netherlands" with 1 trials as a collaborator. Other collaborators include 12 different institutions and companies that were collaborators in the rest 22 trials.

According to Clinical.Site data, the most researched conditions in "St. Anna Ziekenhuis" are "Osteoarthritis" (2 trials), "Acute Respiratory Failure" (1 trials), "Acute Thrombosis of Deep Veins of Proximal Lower Extremity" (1 trials), "Brain Infarction" (1 trials) and "Breast Cancer" (1 trials). Many other conditions were trialed in "St. Anna Ziekenhuis" in a lesser frequency.

Most popular intervention types in "St. Anna Ziekenhuis" are "Drug" (8 trials), "Other" (5 trials), "Device" (4 trials), "Biological" (1 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "1 or 2 cycle(s) HDM (High Dose Melphalan)" (1 trials), "2 cycles of Bortezomib, Lenalidomide, Dexamethasone (VRD)" (1 trials), "Ancrod (Viprinex)" (1 trials) and "Autologous Protein Solution "APS(TM)"" (1 trials). Other intervention names were less common.

The vast majority of trials in "St. Anna Ziekenhuis" are 16 trials for "All" genders, 3 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "St. Anna Ziekenhuis". undefined are not yet recruiting, 2 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in St. Anna Ziekenhuis, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in St. Anna Ziekenhuis, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 7 trials that are defined as “Not Applicable".

St. Anna Ziekenhuis has several departments that took part in Clinical trials: "Knowledge Center for Orthopedic Surgery, St. Anna hospital" - 2 trials